Capstone Wealth Management »

Neurocrine Biosciences shares owned by Capstone Wealth Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Capstone Wealth Management from 13F filings

Historical chart of Capstone Wealth Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Capstone Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Capstone Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $360k 2.1k 168.53

More positions owned by Capstone Wealth Management

Ea Series Trust Brid Omn Sma Etf (BSVO)
Dimensional Etf Trust Us Equi Mark Etf (DFUS)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust World Ex Us Core (DFAX)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Apple (AAPL)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
NVIDIA Corporation (NVDA)

View all positions for Capstone Wealth Management

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences